Cellid Co., Ltd. Logo

Cellid Co., Ltd.

Develops immunotherapeutic vaccines for cancer and infectious diseases.

299660 | KO

Overview

Corporate Details

ISIN(s):
KR7299660001
LEI:
Country:
South Korea
Address:
서울시 관악구 관악로 1 서울대학교 142동 5층, 서울시

Description

Cellid Co., Ltd. is a research and development biotechnology company focused on immunotherapeutic vaccines. The company's activities are centered on two proprietary technology platforms: CeliVax for anti-cancer immunotherapy and an adenovirus vector platform for infectious disease vaccines. The CeliVax platform is used to develop personalized vaccines that utilize a patient's own B cells and monocytes to target specific cancer antigens. The adenovirus vector platform enables the rapid development of safe, non-replicating viral vector vaccines, with a key application being its COVID-19 vaccine candidate. Cellid's pipeline is built upon these core technologies to address unmet medical needs in oncology and virology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.1 KB
2025-09-18 00:00
소송등의제기ㆍ신청(일정금액이상의청구)
Korean HTML 8.3 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1015.8 KB
2025-08-12 00:00
소송등의판결ㆍ결정(일정금액이상의청구)
Korean HTML 7.0 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 28.4 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 25.5 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 25.5 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 25.5 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 27.6 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 26.2 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 27.6 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 26.2 KB
2025-06-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 25.1 KB
2025-06-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 25.1 KB
2025-06-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 25.1 KB

Automate Your Workflow. Get a real-time feed of all Cellid Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cellid Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cellid Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Arcus Biosciences, Inc. Logo
A clinical-stage biopharmaceutical company developing combination therapies for cancer.
United States of America
RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes treatments for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharmaceutical company developing medicines for cardiorenal and gastrointestinal diseases.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharmaceutical company enhancing medicines with its proprietary formulation technology.
United Kingdom
AREC
argenx SE Logo
Develops and commercializes antibody-based therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Develops bacteriophage therapeutics for antibiotic-resistant bacterial infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets in vitro diagnostic (IVD) tests for oncology and bacteriology.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
Clinical-stage biopharma developing oncology drugs for difficult-to-treat diseases.
United States of America
AVBP
ARROWHEAD PHARMACEUTICALS, INC. Logo
Biotechnology company developing RNAi therapies to treat intractable diseases.
United States of America
ARWR
ARS Pharmaceuticals, Inc. Logo
Develops and commercializes needle-free products for administering therapies.
United States of America
SPRY

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.